Skip to main navigation
Go to Cumberland Pharmaceuticals, Inc. homepage
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
Contact
Contact

SEC Filings

Form Description Filer Filing Date View
4 Statement of changes in beneficial ownership of securities KAZIMI A J Mar 18, 2026
View HTML
0001628280-26-019514.pdf
0001628280-26-019514.rtf
0001628280-26-019514.xls
ARS An annual report to security holders Mar 12, 2026
View HTML
0001087294-26-000029.pdf
0001087294-26-000029.rtf
10-K Annual report which provides a comprehensive overview of the company for the past year Mar 09, 2026
View HTML
0001087294-26-000020.pdf
0001087294-26-000020.rtf
0001087294-26-000020.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEFA14A Additional proxy soliciting materials - definitive Mar 09, 2026
View HTML
0001087294-26-000027.pdf
0001087294-26-000027.rtf
0001087294-26-000027.xls
DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") Mar 09, 2026
View HTML
0001087294-26-000025.pdf
0001087294-26-000025.rtf
0001087294-26-000025.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K Report of unscheduled material events or corporate event Mar 03, 2026
View HTML
0001087294-26-000015.pdf
0001087294-26-000015.rtf
0001087294-26-000015.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SCHEDULE 13G SCHEDULE 13G - Description Feb 09, 2026
View HTML
0001075050-26-000006.pdf
0001075050-26-000006.rtf
0001075050-26-000006.xls
8-K Report of unscheduled material events or corporate event Feb 04, 2026
View HTML
0001087294-26-000011.pdf
0001087294-26-000011.rtf
0001087294-26-000011.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
4 Statement of changes in beneficial ownership of securities Krogulski Kenneth Jan 06, 2026
View HTML
0001087294-26-000002.pdf
0001087294-26-000002.rtf
0001087294-26-000002.xls
4 Statement of changes in beneficial ownership of securities Young Caroline Jan 06, 2026
View HTML
0001087294-26-000008.pdf
0001087294-26-000008.rtf
0001087294-26-000008.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
KAZIMI A J
Mar 18, 2026
View HTML
0001628280-26-019514.pdf
0001628280-26-019514.rtf
0001628280-26-019514.xls
Form: ARS
Description: An annual report to security holders
Mar 12, 2026
View HTML
0001087294-26-000029.pdf
0001087294-26-000029.rtf
Form: 10-K
Description: Annual report which provides a comprehensive overview of the company for the past year
Mar 09, 2026
View HTML
0001087294-26-000020.pdf
0001087294-26-000020.rtf
0001087294-26-000020.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: DEFA14A
Description: Additional proxy soliciting materials - definitive
Mar 09, 2026
View HTML
0001087294-26-000027.pdf
0001087294-26-000027.rtf
0001087294-26-000027.xls
Form: DEF 14A
Description: Official notification to shareholders of matters to be brought to a vote ("Proxy")
Mar 09, 2026
View HTML
0001087294-26-000025.pdf
0001087294-26-000025.rtf
0001087294-26-000025.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 8-K
Description: Report of unscheduled material events or corporate event
Mar 03, 2026
View HTML
0001087294-26-000015.pdf
0001087294-26-000015.rtf
0001087294-26-000015.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: SCHEDULE 13G
Description: SCHEDULE 13G - Description
Feb 09, 2026
View HTML
0001075050-26-000006.pdf
0001075050-26-000006.rtf
0001075050-26-000006.xls
Form: 8-K
Description: Report of unscheduled material events or corporate event
Feb 04, 2026
View HTML
0001087294-26-000011.pdf
0001087294-26-000011.rtf
0001087294-26-000011.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 4
Description: Statement of changes in beneficial ownership of securities
Krogulski Kenneth
Jan 06, 2026
View HTML
0001087294-26-000002.pdf
0001087294-26-000002.rtf
0001087294-26-000002.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
Young Caroline
Jan 06, 2026
View HTML
0001087294-26-000008.pdf
0001087294-26-000008.rtf
0001087294-26-000008.xls
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »
Displaying 1 - 10 of 420 results

Data provided by Kaleidoscope.

© 2026 Cumberland Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy
Accessibility Statement
Terms of Use